CRISPR Therapeutics AG (CRSP) Net Shares Issued and Repurchased (2015 - 2026)

CRISPR Therapeutics AG has disclosed Net Shares Issued and Repurchased across 12 years of filings, most recently posting $716931.0 for Q1 2026.

• In Q1 2026, Net Shares Issued and Repurchased fell 19.87% year-over-year to $716931.0; the TTM figure through Mar 2026 stood at $716931.0 (down 19.87% YoY), while the FY2025 annual figure was $1.4 million, down 11.18% from the prior year.
• Net Shares Issued and Repurchased came in at $716931.0 for Q1 2026 at CRISPR Therapeutics AG, down from $1.4 million in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $1.9 million in Q4 2023 to a low of $150000.0 in Q3 2022.
• Average Net Shares Issued and Repurchased over 5 years is $1.1 million, with a median of $1.1 million recorded in 2023.
• Year-over-year, Net Shares Issued and Repurchased jumped 50.8% in 2023 and sank 34.38% in 2024.
• Over 5 years, Net Shares Issued and Repurchased stood at $1.5 million in 2022, then gained by 24.65% to $1.9 million in 2023, then slipped by 15.8% to $1.6 million in 2024, then dropped by 11.18% to $1.4 million in 2025, then sank by 48.47% to $716931.0 in 2026.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $716931.0 in Q1 2026, $1.4 million in Q4 2025, and $894655.0 in Q1 2025.